Edition:
United States

Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

20.75EUR
19 Jul 2018
Change (% chg)

€0.10 (+0.48%)
Prev Close
€20.65
Open
€20.65
Day's High
€20.75
Day's Low
€20.65
Volume
121
Avg. Vol
5,166
52-wk High
€28.25
52-wk Low
€19.50

Chart for

About

Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €138.10
Shares Outstanding(Mil.): 5.93
Dividend: --
Yield (%): --

Financials

  ALCAR.PA Industry Sector
P/E (TTM): -- 32.18 32.76
EPS (TTM): -3.81 -- --
ROI: -126.97 13.91 14.61
ROE: -1,028.47 16.75 16.34

BRIEF-Carmat Continuing Progress In Line With Objective Of Obtaining CE Marking In 2019

* OPENING OF NEW BOIS-D'ARCY SITE FOR LARGE-SCALE PRODUCTION OF PROSTHESES

Apr 05 2018

BRIEF-Carmat Says To Keep Patient Enrollment Pace In Line With Its Goal To Finalize Pivotal Study By Year-End

* SAYS ADVANCES THE INTERNATIONALIZATION OF THE PIVOTAL STUDY AND OBTAINS THE APPROVAL TO PERFORM IMPLANTS IN DENMARK‍​

Feb 20 2018

BRIEF-Carmat To Internationalize PIVOTAL Study And To Perform Implants In Denmark

* CARMAT ADVANCES THE INTERNATIONALIZATION OF THE PIVOTAL STUDY AND OBTAINS THE APPROVAL TO PERFORM IMPLANTS IN DENMARK Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 20 2018

BRIEF-‍Carmat Launches A Capital Increase For An Initial Amount Of EUR 46 Million​

* ‍CARMAT LAUNCHES A CAPITAL INCREASE FOR AN INITIAL AMOUNT OF EUR 46 MILLION​

Jan 29 2018

Earnings vs. Estimates